N/A
Completed N=96
A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)
Source: ClinicalTrials.gov NCT01101958 ↗Enrolled (actual)
96
Serious AEs
13.8%
Results posted
Jan 2014
Primary outcomePrimary: Lung Volume Change — 56; 6 percent decrease in lung volume
Summary
Use of the Chartis® Assessment System prior to EBV Treatment
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Lung Volume Change |
56; 6 | — |
Eligibility Criteria
Inclusion Criteria
- Heterogeneous emphysema
- Able to obtain a Chartis value during Assessment
Exclusion Criteria
- Any co-existing major medical problems that would not make it possible for the subject to tolerate a bronchoscopic procedure.
Data sourced from ClinicalTrials.gov (NCT01101958). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.